Cargando…

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Despite numerous research efforts, drug delivery through the oral route remains a major challenge to formulation scientists. The oral delivery of drugs poses a significant challenge because more than 40% of new chemical entities are practically insoluble in water. Low aqueous solubility is the main...

Descripción completa

Detalles Bibliográficos
Autores principales: Munnangi, Siva Ram, Youssef, Ahmed Adel Ali, Narala, Nagarjuna, Lakkala, Preethi, Narala, Sagar, Vemula, Sateesh Kumar, Repka, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156076/
https://www.ncbi.nlm.nih.gov/pubmed/37138135
http://dx.doi.org/10.1007/s11095-023-03517-w
_version_ 1785036464874061824
author Munnangi, Siva Ram
Youssef, Ahmed Adel Ali
Narala, Nagarjuna
Lakkala, Preethi
Narala, Sagar
Vemula, Sateesh Kumar
Repka, Michael
author_facet Munnangi, Siva Ram
Youssef, Ahmed Adel Ali
Narala, Nagarjuna
Lakkala, Preethi
Narala, Sagar
Vemula, Sateesh Kumar
Repka, Michael
author_sort Munnangi, Siva Ram
collection PubMed
description Despite numerous research efforts, drug delivery through the oral route remains a major challenge to formulation scientists. The oral delivery of drugs poses a significant challenge because more than 40% of new chemical entities are practically insoluble in water. Low aqueous solubility is the main problem encountered during the formulation development of new actives and for generic development. A complexation approach has been widely investigated to address this issue, which subsequently improves the bioavailability of these drugs. This review discusses the various types of complexes such as metal complex (drug-metal ion), organic molecules (drug-caffeine or drug-hydrophilic polymer), inclusion complex (drug-cyclodextrin), and pharmacosomes (drug-phospholipids) that improves the aqueous solubility, dissolution, and permeability of the drug along with the numerous case studies reported in the literature. Besides improving solubility, drug-complexation provides versatile functions like improving stability, reducing the toxicity of drugs, increasing or decreasing the dissolution rate, and enhancing bioavailability and biodistribution. Apart, various methods to predict the stoichiometric ratio of reactants and the stability of the developed complex are discussed. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10156076
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-101560762023-05-09 Drug complexes: Perspective from Academic Research and Pharmaceutical Market Munnangi, Siva Ram Youssef, Ahmed Adel Ali Narala, Nagarjuna Lakkala, Preethi Narala, Sagar Vemula, Sateesh Kumar Repka, Michael Pharm Res Review Paper Despite numerous research efforts, drug delivery through the oral route remains a major challenge to formulation scientists. The oral delivery of drugs poses a significant challenge because more than 40% of new chemical entities are practically insoluble in water. Low aqueous solubility is the main problem encountered during the formulation development of new actives and for generic development. A complexation approach has been widely investigated to address this issue, which subsequently improves the bioavailability of these drugs. This review discusses the various types of complexes such as metal complex (drug-metal ion), organic molecules (drug-caffeine or drug-hydrophilic polymer), inclusion complex (drug-cyclodextrin), and pharmacosomes (drug-phospholipids) that improves the aqueous solubility, dissolution, and permeability of the drug along with the numerous case studies reported in the literature. Besides improving solubility, drug-complexation provides versatile functions like improving stability, reducing the toxicity of drugs, increasing or decreasing the dissolution rate, and enhancing bioavailability and biodistribution. Apart, various methods to predict the stoichiometric ratio of reactants and the stability of the developed complex are discussed. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-05-03 /pmc/articles/PMC10156076/ /pubmed/37138135 http://dx.doi.org/10.1007/s11095-023-03517-w Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Paper
Munnangi, Siva Ram
Youssef, Ahmed Adel Ali
Narala, Nagarjuna
Lakkala, Preethi
Narala, Sagar
Vemula, Sateesh Kumar
Repka, Michael
Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title_full Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title_fullStr Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title_full_unstemmed Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title_short Drug complexes: Perspective from Academic Research and Pharmaceutical Market
title_sort drug complexes: perspective from academic research and pharmaceutical market
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156076/
https://www.ncbi.nlm.nih.gov/pubmed/37138135
http://dx.doi.org/10.1007/s11095-023-03517-w
work_keys_str_mv AT munnangisivaram drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT youssefahmedadelali drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT naralanagarjuna drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT lakkalapreethi drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT naralasagar drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT vemulasateeshkumar drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket
AT repkamichael drugcomplexesperspectivefromacademicresearchandpharmaceuticalmarket